title: [Recommendations for patients with Crohn's disease starting treatment with adalimumab: a rapid guide].
authors.affiliation: Hospital de Galdakao, Galdakao, Vizcaya, Spain.
authors.forename: José Luis
authors.initials: JL
authors.lastname: Cabriada
authors.forename: Valle
authors.initials: V
authors.lastname: García Sánchez
authors.forename: Fernando
authors.initials: F
authors.lastname: Gomollón
authors.forename: Joaquín
authors.initials: J
authors.lastname: Hinojosa
authors.forename: Antonio
authors.initials: A
authors.lastname: López San Román
authors.forename: Juan Luis
authors.initials: JL
authors.lastname: Mendoza
authors.forename: Miguel
authors.initials: M
authors.lastname: Mínguez
authors.forename: Elena
authors.initials: E
authors.lastname: Ricart
authors.forename: Cristina
authors.initials: C
authors.lastname: Saro
mesh_terms: D000068879:Adalimumab; D000465:Algorithms; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab